Paul Kreye

Title: Paul Kreye: Innovator in Pharmaceutical Processes

Introduction

Paul Kreye is a notable inventor based in Ingelheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of important compounds. With a total of 3 patents to his name, Kreye's work has had a substantial impact on the industry.

Latest Patents

Kreye's latest patents focus on the process for preparing (R)-salbutamol. The disclosed processes involve preparing levosalbutamol or its pharmacologically acceptable salts on an industrial scale. Asymmetric hydrogenation is utilized as the key step, along with a special sequence of subsequent steps. Rhodium is used as a catalyst, paired with a chiral bidentate phosphine ligand, specifically (2R, 4R)-4-(dicyclohexylphosphino)-2-(diphenyl-phosphino-methyl)-N-methyl-aminocarbonyl-pyrrolidine, as the catalyst system.

Career Highlights

Throughout his career, Kreye has worked with prominent companies in the pharmaceutical sector. Notably, he has been associated with Boehringer Ingelheim Pharma GmbH & Co. KG and Boehringer Ingelheim Pharma KG. His expertise in pharmaceutical processes has been instrumental in advancing the production of critical medications.

Collaborations

Kreye has collaborated with several professionals in his field, including Alfons Lenhart and Franz Dietrich Klingler. These collaborations have contributed to the successful development of innovative processes in pharmaceuticals.

Conclusion

Paul Kreye's contributions to the pharmaceutical industry through his innovative processes and collaborations highlight his importance as an inventor. His work continues to influence the preparation of essential compounds, showcasing the impact of his inventions on healthcare.